Diagnostic methods currently used for bladder cancer are cystoscopy and urine cytology.
Cystoscopy is an invasive tool and has low sensitivity for carcinoma in situ. Urine cytology is …

Bladder Cancer (BC) represents a clinical and social challenge due to its high incidence
and recurrence rates, as well as the limited advances in effective disease management …

Early cancer detection is crucial for successful treatment, and biomarkers play a vital role in
this process. The determination of biomarkers using electrochemical chemosensors is a well …

For over 80 years, cystoscopy has remained the gold-standard for detecting tumours of the
urinary bladder. Since bladder tumours have a tendency to recur and progress, many …

The types of urothelial carcinoma (UC) include urothelial bladder cancer and upper tract
urothelial carcinoma. Current diagnostic techniques cannot meet the needs of patients …

Carcinoembryonic antigen (CEA) is an important biomarker in cancer diagnosis. Here, we
present an efficient, selective lateral-flow immunoassay (LFIA) based on magnetic …

A selective, fast acting and eco–friendly fluorescence immunoassay technique based on
Nitrogen doped carbon dots (NCDs) is proposed for the detection of Nuclear Matrix Protein …

Oral cancer is one of the most common malignancies worldwide, accounting for 2% of all
cases annually and 1.8% of all cancer deaths. To date, tissue biopsy and histopathological …

Urothelial carcinoma (UC) is the ninth most prevalent malignancy worldwide. Noninvasive
and efficient biomarkers with high accuracy are imperative for the surveillance and …

A sensitive label-free electrochemical immunosensor was developed based on Au@ Pd/Ag
yolk-bimetallic shell nanoparticles (Au@ Pd/Ag NPs) and amination graphene (NH 2-GS) for …